INS and diabetes mellitus: Through a variety of mechanisms, LC clearly contributes to dysglycemia by interfering with the insulin-glucose metabolism, while DM predisposes to liver disease progression and a higher risk of serious complications of LC, presuming that patients with compensated LC and concomitant DM may be at greater risk of decompensating events [10].